Identification of recurrent regulated alternative splicing events across human solid tumors

Nucleic Acids Research

Volumn 43, Issue 10, 2015, Pages 5130-5144

  Danan Gotthold, Miri ^a   Golan Gerstl, Regina ^b   Eisenberg, Eli ^c   Meir, Keren ^d   Karni, Rotem ^b   Levanon, Erez Y ^a  

^a BAR ILAN UNIVERSITY   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c TEL AVIV UNIVERSITY   (Israel)

^d HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

ALTERNATIVE RNA SPLICING; ARTICLE; BREAST CARCINOMA; CANCER CLASSIFICATION; CARCINOGENESIS; CLEAR CELL CARCINOMA; COLON ADENOCARCINOMA; CONTROLLED STUDY; DEREGULATION; EXON; GENE CASSETTE; GENE EXPRESSION PROFILING; GENE FUNCTION; GENE IDENTIFICATION; GENE MUTATION; GENETIC REGULATION; HUMAN; HUMAN TISSUE; KIDNEY CARCINOMA; LIVER CELL CARCINOMA; LUNG ADENOCARCINOMA; PRIORITY JOURNAL; PROSTATE ADENOCARCINOMA; SEQUENCE ALIGNMENT; SEQUENCE ANALYSIS; SOLID TUMOR; THYROID CARCINOMA; ANTAGONISTS AND INHIBITORS; GENETICS; METABOLISM; NEOPLASM; REGULATORY RNA SEQUENCE;

QKI PROTEIN, HUMAN; RBFOX2 PROTEIN, HUMAN; REGULATORY RNA SEQUENCE; REPRESSOR PROTEIN; RNA BINDING PROTEIN;

ALTERNATIVE SPLICING; EXONS; HUMANS; NEOPLASMS; REGULATORY SEQUENCES, RIBONUCLEIC ACID; REPRESSOR PROTEINS; RNA-BINDING PROTEINS;

EID: 84931287860     PISSN: 03051048     EISSN: 13624962     Source Type: Journal    
DOI: 10.1093/nar/gkv210     Document Type: Article

References (90)

1. Wang, E.T., Sandberg, R., Luo, S., Khrebtukova, I., Zhang, L., Mayr, C., Kingsmore, S.F., Schroth, G.P. and Burge, C.B. (2008) Alternative isoform regulation in human tissue transcriptomes. Nature, 456, 470-476.
2. Pan, Q., Shai, O., Lee, L.J., Frey, B.J. and Blencowe, B.J. (2008) Deep surveying of alternative splicing complexity in the human transcriptome by high-throughput sequencing. Nat. Genet., 40, 1413-1415.
3. Stamm, S., Ben-Ari, S., Rafalska, I., Tang, Y., Zhang, Z., Toiber, D., Thanaraj, T.A. and Soreq, H. (2005) Function of alternative splicing. Gene, 344, 1-20.
4. Venables, J.P. (2004) Aberrant and alternative splicing in cancer. Cancer Res., 64, 7647-7654.
5. Liu, S. and Cheng, C. (2013) Alternative RNA splicing and cancer. Wiley Interdiscip. Rev. RNA, 4, 547-566.
6. David, C.J. and Manley, J.L. (2010) Alternative pre-mRNA splicing regulation in cancer: pathways and programs unhinged. Genes Dev., 24, 2343-2364.
7. Venables, J.P., Klinck, R., Koh, C., Gervais-Bird, J., Bramard, A., Inkel, L., Durand, M., Couture, S., Froehlich, U., Lapointe, E. et al. (2009) Cancer-associated regulation of alternative splicing. Nat. Struct. Mol. Biol., 16, 670-676.
8. Gardina, P.J., Clark, T.A., Shimada, B., Staples, M.K., Yang, Q., Veitch, J., Schweitzer, A., Awad, T., Sugnet, C., Dee, S. et al. (2006) Alternative splicing and differential gene expression in colon cancer detected by a whole genome exon array. BMC Genomics, 7, 325.
9. Shapiro, I.M., Cheng, A.W., Flytzanis, N.C., Balsamo, M., Condeelis, J.S., Oktay, M.H., Burge, C.B. and Gertler, F.B. (2011) An EMT-driven alternative splicing program occurs in human breast cancer and modulates cellular phenotype. PLoS Genet., 7, e1002218.
10. Misquitta-Ali, C.M., Cheng, E., O'Hanlon, D., Liu, N., McGlade, C.J., Tsao, M.S. and Blencowe, B.J. (2011) Global profling and molecular characterization of alternative splicing events misregulated in lung cancer. Mol. Cell. Biol., 31, 138-150.
11. Germann, S., Gratadou, L., Dutertre, M. and Auboeuf, D. (2012) Splicing programs and cancer. J. Nucleic Acids, 2012, 269570.
12. Lapuk, A., Marr, H., Jakkula, L., Pedro, H., Bhattacharya, S., Purdom, E., Hu, Z., Simpson, K., Pachter, L., Durinck, S. et al. (2010) Exon-level microarray analyses identify alternative splicing programs in breast cancer. Mol. Cancer Res., 8, 961-974.
13. Jin, W., Bruno, I.G., Xie, T.-X., Sanger, L.J. and Cote, G.J. (2003) Polypyrimidine tract-binding protein down-regulates fbroblast growth factor receptor 1 alpha-exon inclusion. Cancer Res., 63, 6154-6157.
14. He, X., Pool, M., Darcy, K.M., Lim, S.B., Auersperg, N., Coon, J.S. and Beck, W.T. (2007) Knockdown of polypyrimidine tract-binding protein suppresses ovarian tumor cell growth and invasiveness in vitro. Oncogene, 26, 4961-4968.
15. Babic, I., Sharma, S. and Black, D.L. (2009) A role for polypyrimidine tract binding protein in the establishment of focal adhesions. Mol. Cell. Biol., 29, 5564-5577.
16. Cheung, H.C., Hai, T., Zhu, W., Baggerly, K.A., Tsavachidis, S., Krahe, R. and Cote, G.J. (2009) Splicing factors PTBP1 and PTBP2 promote proliferation and migration of glioma cell lines. Brain, 132, 2277-2288.
17. Karni, R., de Stanchina, E., Lowe, S.W., Sinha, R., Mu, D. and Krainer, A.R. (2007) The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol., 14, 185-193.
18. Anczuków, O., Rosenberg, A.Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S.K. and Krainer, A.R. (2012) The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nat. Struct. Mol. Biol., 19, 220-228.
19. Grosso, A.R., Martins, S. and Carmo-Fonseca, M. (2008) The emerging role of splicing factors in cancer. EMBO Rep., 9, 1087-1093.
20. Licatalosi, D.D. and Darnell, R.B. (2010) RNA processing and its regulation: global insights into biological networks. Nat. Rev. Genet., 11, 75-87.
21. Novikov, L., Park, J.W., Chen, H., Klerman, H., Jalloh, A.S. and Gamble, M.J. (2011) QKI-mediated alternative splicing of the histone variant MacroH2A1 regulates cancer cell proliferation. Mol. Cell. Biol., 31, 4244-4255.
22. Frasca, F., Pandini, G., Scalia, P., Sciacca, L., Mineo, R., Costantino, A., Goldfne, I.D., Belfore, A. and Vigneri, R. (1999) Insulin Receptor Isoform A, a Newly Recognized, High-Affnity Insulin-Like Growth Factor II Receptor in Fetal and Cancer Cells. Mol. Cell. Biol., 19, 3278-3288.
23. Brinkman, B.M.N. (2004) Splice variants as cancer biomarkers. Clin. Biochem., 37, 584-594.
24. Ge, K., DuHadaway, J., Du, W., Herlyn, M., Rodeck, U. and Prendergast, G.C. (1999) Mechanism for elimination of a tumor suppressor: Aberrant splicing of a brain-specifc exon causes loss of function of Bin1 in melanoma. Proc. Natl. Acad. Sci. U.S.A., 96, 9689-9694.
25. Clower, C. V, Chatterjee, D., Wang, Z., Cantley, L.C., Vander Heiden, M.G. and Krainer, A.R. (2010) The alternative splicing repressors hnRNP A1/A2 and PTB infuence pyruvate kinase isoform expression and cell metabolism. Proc. Natl. Acad. Sci. U. S. A., 107, 1894-1899.
26. David, C.J., Chen, M., Assanah, M., Canoll, P. and Manley, J.L. (2010) HnRNP proteins controlled by c-Myc deregulate pyruvate kinase mRNA splicing in cancer. Nature, 463, 364-368.
27. Dueck, M., Riedl, S., Hinz, U., Tandara, A., Möller, P., Herfarth, C. and Faissner, A. (1999) Detection of tenascin-C isoforms in colorectal mucosa, ulcerative colitis, carcinomas and liver metastases. Int. J. Cancer, 82, 477-483.
28. Hindermann, W., Berndt, A., Borsi, L., Luo, X., Hyckel, P., Katenkamp, D. and Kosmehl, H. (1999) Synthesis and protein distribution of the unspliced large tenascin-C isoform in oral squamous cell carcinoma. J. Pathol., 189, 475-480.
29. Borsi, L., Carnemolla, B., Nicolò, G., Spina, B., Tanara, G. and Zardi, L. (1992) Expression of different tenascin isoforms in normal, hyperplastic and neoplastic human breast tissues. Int. J. Cancer, 52, 688-692.
30. Cheung, H.C., Baggerly, K.A., Tsavachidis, S., Bachinski, L.L., Neubauer, V.L., Nixon, T.J., Aldape, K.D., Cote, G.J. and Krahe, R. (2008) Global analysis of aberrant pre-mRNA splicing in glioblastoma using exon expression arrays. BMC Genomics, 9, 216.
31. Maimon, A., Mogilevsky, M., Shilo, A., Golan-Gerstl, R., Obiedat, A., Ben-Hur, V., Lebenthal-Loinger, I., Stein, I., Reich, R., Beenstock, J. et al. (2014) Mnk2 alternative splicing modulates the p38-MAPK pathway and impacts Ras-induced transformation. Cell Rep., 7, 501-513.
32. Ben-Hur, V., Denichenko, P., Siegfried, Z., Maimon, A., Krainer, A., Davidson, B. and Karni, R. (2013) S6K1 alternative splicing modulates its oncogenic activity and regulates mTORC1. Cell Rep., 3, 103-115.
33. Thorsen, K., Sørensen, K.D., Brems-Eskildsen, A.S., Modin, C., Gaustadnes, M., Hein, A.-M.K., Kruhøffer, M., Laurberg, S., Borre, M., Wang, K. et al. (2008) Alternative splicing in colon, bladder, and prostate cancer identifed by exon array analysis. Mol. Cell. Proteomics, 7, 1214-1224.
34. Weinstein, J.N., Collisson, E.A., Mills, G.B., Shaw, K.R.M., Ozenberger, B.A., Ellrott, K., Shmulevich, I., Sander, C. and Stuart, J.M. (2013) The Cancer Genome Atlas Pan-Cancer analysis project. Nat. Genet., 45, 1113-1120.
35. Dobin, A., Davis, C.A., Schlesinger, F., Drenkow, J., Zaleski, C., Jha, S., Batut, P., Chaisson, M. and Gingeras, T.R. (2013) STAR: ultrafast universal RNA-seq aligner. Bioinformatics, 29, 15-21.
36. Merkin, J., Russell, C., Chen, P. and Burge, C.B. (2012) Evolutionary dynamics of gene and isoform regulation in Mammalian tissues. Science, 338, 1593-1599.
37. Quinlan, A.R. and Hall, I.M. (2010) BEDTools: a fexible suite of utilities for comparing genomic features. Bioinformatics, 26, 841-842.
38. The Cancer Genome Atlas Research Network. (2012) Comprehensive molecular portraits of human breast tumours. Nature, 490, 61-70.
39. The Cancer Genome Atlas Research Network. (2012) Comprehensive molecular characterization of human colon and rectal cancer. Nature, 487, 330-337.
40. The Cancer Genome Atlas Research Network. (2013) Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature, 499, 43-49.
41. The Cancer Genome Atlas Research Network. (2012) Comprehensive genomic characterization of squamous cell lung cancers. Nature, 489, 519-525.
42. Lappalainen, T., Sammeth, M., Friedländer, M.R., 't Hoen, P.A.C., Monlong, J., Rivas, M.A., Gonzàlez-Porta, M., Kurbatova, N., Griebel, T., Ferreira, P.G. et al. (2013) Transcriptome and genome sequencing uncovers functional variation in humans. Nature, 501, 506-511.
43. Fiegen, D., Haeusler, L.-C., Blumenstein, L., Herbrand, U., Dvorsky, R., Vetter, I.R. and Ahmadian, M.R. (2004) Alternative splicing of Rac1 generates Rac1b, a self-activating GTPase. J. Biol. Chem., 279, 4743-4749.
44. Resch, A., Xing, Y., Alekseyenko, A., Modrek, B. and Lee, C. (2004) Evidence for a subpopulation of conserved alternative splicing events under selection pressure for protein reading frame preservation. Nucleic Acids Res., 32, 1261-1269.
45. Venables, J.P., Brosseau, J.-P., Gadea, G., Klinck, R., Prinos, P., Beaulieu, J.-F., Lapointe, E., Durand, M., Thibault, P., Tremblay, K. et al. (2013) RBFOX2 is an important regulator of mesenchymal tissue-specifc splicing in both normal and cancer tissues. Mol. Cell. Biol., 33, 396-405.
46. Brosseau, J.-P., Lucier, J.-F., Nwilati, H., Thibault, P., Garneau, D., Gendron, D., Durand, M., Couture, S., Lapointe, E., Prinos, P. et al. (2014) Tumor microenvironment-associated modifcations of alternative splicing. RNA, 20, 189-201.
47. De Craene, B. and Berx, G. (2013) Regulatory networks defning EMT during cancer initiation and progression. Nat. Rev. Cancer, 13, 97-110.
48. Pujuguet, P., Hammann, A., Moutet, M., Samuel, J.L., Martin, F. and Martin, M. (1996) Expression of fbronectin ED-A+ and ED-B+ isoforms by human and experimental colorectal cancer. Contribution of cancer cells and tumor-associated myofbroblasts. Am. J. Pathol., 148, 579-592.
49. Matsui, S., Takahashi, T., Oyanagi, Y., Takahashi, S., Boku, S., Takahashi, K., Furukawa, K., Arai, F. and Asakura, H. (1997) Expression, localization and alternative splicing pattern of fbronectin messenger RNA in fbrotic human liver and hepatocellular carcinoma. J. Hepatol., 27, 843-853.
50. White, E.S., Baralle, F.E. and Muro, A.F. (2008) New insights into form and function of fbronectin splice variants. J. Pathol., 216, 1-14.
51. Yi, C.-H., Smith, D.J., West, W.W. and Hollingsworth, M.A. (2007) Loss of fbulin-2 expression is associated with breast cancer progression. Am. J. Pathol., 170, 1535-1545.
52. Dunwell, T.L., Hesson, L.B., Pavlova, T., Zabarovska, V., Kashuba, V., Catchpoole, D., Chiaramonte, R., Brini, A.T., Griffths, M., Maher, E.R. et al. (2009) Epigenetic analysis of childhood acute lymphoblastic leukemia. Epigenetics, 4, 185-193.
53. Hill, V.K., Hesson, L.B., Dansranjavin, T., Dallol, A., Bieche, I., Vacher, S., Tommasi, S., Dobbins, T., Gentle, D., Euhus, D. et al. (2010) Identifcation of 5 novel genes methylated in breast and other epithelial cancers. Mol. Cancer, 9, 51.
54. Chattopadhyay, I., Singh, A., Phukan, R., Purkayastha, J., Kataki, A., Mahanta, J., Saxena, S. and Kapur, S. (2010) Genome-wide analysis of chromosomal alterations in patients with esophageal squamous cell carcinoma exposed to tobacco and betel quid from high-risk area in India. Mutat. Res.-Genet. Toxicol. Environ. Mutagen., 696, 130-138.
55. Baird, B.N., Schliekelman, M.J., Ahn, Y.H., Chen, Y., Roybal, J.D., Gill, B.J., Mishra, D.K., Erez, B., O'Reilly, M., Yang, Y. et al. (2013) Fibulin-2 Is a driver of malignant progression in lung adenocarcinoma. PLoS One, 8, e67054.
56. Law, E.W.L., Cheung, A.K.L., Kashuba, V.I., Pavlova, T. V, Zabarovsky, E.R., Lung, H.L., Cheng, Y., Chua, D., Lai-wan Kwong, D., Tsao, S.W. et al. (2012) Anti-angiogenic and tumor-suppressive roles of candidate tumor-suppressor gene, Fibulin-2, in nasopharyngeal carcinoma. Oncogene, 31, 728-738.
57. Puente Navazo, M.D., Valmori, D. and Ruegg, C. (2001) The alternatively spliced domain TnFnIII A1A2 of the extracellular matrix protein tenascin-C suppresses activation-induced T lymphocyte proliferation and cytokine production. J. Immunol., 167, 6431-6440.
58. Murphy-Ullrich, J.E. (1991) Focal adhesion integrity is downregulated by the alternatively spliced domain of human tenascin [published erratum appears in J Cell Biol 1992 Feb;116(3):833]. J. Cell Biol., 115, 1127-1136.
59. Szklarczyk, D., Franceschini, A., Kuhn, M., Simonovic, M., Roth, A., Minguez, P., Doerks, T., Stark, M., Muller, J., Bork, P. et al. (2011) The STRING database in 2011: functional interaction networks of proteins, globally integrated and scored. Nucleic Acids Res., 39, D561-D568.
60. Ule, J., Ule, A., Spencer, J., Williams, A., Hu, J.-S., Cline, M., Wang, H., Clark, T., Fraser, C., Ruggiu, M. et al. (2005) Nova regulates brain-specifc splicing to shape the synapse. Nat. Genet., 37, 844-852.
61. Braeutigam, C., Rago, L., Rolke, A., Waldmeier, L., Christofori, G. and Winter, J. (2013) The RNA-binding protein Rbfox2: an essential regulator of EMT-driven alternative splicing and a mediator of cellular invasion. Oncogene, doi:10.1038/onc.2013.50.
62. Zong, F.-Y., Fu, X., Wei, W.-J., Luo, Y.-G., Heiner, M., Cao, L.-J., Fang, Z., Fang, R., Lu, D., Ji, H. et al. (2014) The RNA-binding protein QKI suppresses cancer-associated aberrant splicing. PLoS Genet., 10, e1004289.
63. Jin, Y., Suzuki, H., Maegawa, S., Endo, H., Sugano, S., Hashimoto, K., Yasuda, K. and Inoue, K. (2003) A vertebrate RNA-binding protein Fox-1 regulates tissue-specifc splicing via the pentanucleotide GCAUG. EMBO J., 22, 905-912.
64. Ponthier, J.L., Schluepen, C., Chen, W., Lersch, R.A., Gee, S.L., Hou, V.C., Lo, A.J., Short, S.A., Chasis, J.A., Winkelmann, J.C. et al. (2006) Fox-2 splicing factor binds to a conserved intron motif to promote inclusion of protein 4.1R alternative exon 16. J. Biol. Chem., 281, 12468-12474.
65. Auweter, S.D., Fasan, R., Reymond, L., Underwood, J.G., Black, D.L., Pitsch, S. and Allain, F.H.-T. (2006) Molecular basis of RNA recognition by the human alternative splicing factor Fox-1. EMBO J., 25, 163-173.
66. Llorian, M., Schwartz, S., Clark, T.A., Hollander, D., Tan, L.-Y., Spellman, R., Gordon, A., Schweitzer, A.C., de la Grange, P., Ast, G. et al. (2010) Position-dependent alternative splicing activity revealed by global profling of alternative splicing events regulated by PTB. Nat. Struct. Mol. Biol., 17, 1114-1123.
67. Xue, Y., Zhou, Y., Wu, T., Zhu, T., Ji, X., Kwon, Y.S., Zhang, C., Yeo, G., Black, D.L., Sun, H. et al. (2009) Genome-wide analysis of PTB-RNA interactions reveals a strategy used by the general splicing repressor to modulate exon inclusion or skipping. Mol. Cell, 36, 996-1006.
68. Marquis, J., Paillard, L., Audic, Y., Cosson, B., Danos, O., Le Bec, C. and Osborne, H.B. (2006) CUG-BP1/CELF1 requires UGU-rich sequences for high-affnity binding. Biochem. J., 400, 291-301.
69. Faustino, N.A. and Cooper, T.A. (2005) Identifcation of putative new splicing targets for ETR-3 using sequences identifed by systematic evolution of ligands by exponential enrichment. Mol. Cell. Biol., 25, 879-887.
70. Galarneau, A. and Richard, S. (2005) Target RNA motif and target mRNAs of the Quaking STAR protein. Nat. Struct. Mol. Biol., 12, 691-698.
71. Goers, E.S., Purcell, J., Voelker, R.B., Gates, D.P. and Berglund, J.A. (2010) MBNL1 binds GC motifs embedded in pyrimidines to regulate alternative splicing. Nucleic Acids Res., 38, 2467-2484.
72. Charizanis, K., Lee, K.-Y., Batra, R., Goodwin, M., Zhang, C., Yuan, Y., Shiue, L., Cline, M., Scotti, M.M., Xia, G. et al. (2012) Muscleblind-like 2-mediated alternative splicing in the developing brain and dysregulation in myotonic dystrophy. Neuron, 75, 437-450.
73. Wang, E.T., Cody, N.A.L., Jog, S., Biancolella, M., Wang, T.T., Treacy, D.J., Luo, S., Schroth, G.P., Housman, D.E., Reddy, S. et al. (2012) Transcriptome-wide regulation of pre-mRNA splicing and mRNA localization by muscleblind proteins. Cell, 150, 710-724.
74. Yeo, G.W., Coufal, N.G., Liang, T.Y., Peng, G.E., Fu, X.-D. and Gage, F.H. (2009) An RNA code for the FOX2 splicing regulator revealed by mapping RNA-protein interactions in stem cells. Nat. Struct. Mol. Biol., 16, 130-137.
75. Zhang, C., Zhang, Z., Castle, J., Sun, S., Johnson, J., Krainer, A.R. and Zhang, M.Q. (2008) Defning the regulatory network of the tissue-specifc splicing factors Fox-1 and Fox-2. Genes Dev., 22, 2550-2563.
76. Lovci, M.T., Ghanem, D., Marr, H., Arnold, J., Gee, S., Parra, M., Liang, T.Y., Stark, T.J., Gehman, L.T., Hoon, S. et al. (2013) Rbfox proteins regulate alternative mRNA splicing through evolutionarily conserved RNA bridges. Nat. Struct. Mol. Biol., 20, 1434-1442.
77. Gu, Y.-C., Nilsson, K., Eng, H. and Ekblom, M. (2000) Association of extracellular matrix proteins fbulin-1 and fbulin-2 with fbronectin in bone marrow stroma. Br. J. Haematol., 109, 305-313.
78. Kalluri, R. and Weinberg, R.A. (2009) The basics of epithelial-mesenchymal transition. J. Clin. Invest., 119, 1420-1428.
79. Chen, D., Gassenmaier, M., Maruschke, M., Riesenberg, R., Pohla, H., Stief, C.G., Zimmermann, W. and Buchner, A. (2014) Expression and prognostic signifcance of a comprehensive epithelial-mesenchymal transition gene set in renal cell carcinoma. J. Urol., 191, 479-486.
80. Chuang, M.-J., Sun, K.-H., Tang, S.-J., Deng, M.-W., Wu, Y.-H., Sung, J.-S., Cha, T.-L. and Sun, G.-H. (2008) Tumor-derived tumor necrosis factor-alpha promotes progression and epithelial-mesenchymal transition in renal cell carcinoma cells. Cancer Sci., 99, 905-913.
81. Zhou, C., Licciulli, S., Avila, J.L., Cho, M., Troutman, S., Jiang, P., Kossenkov, A. V, Showe, L.C., Liu, Q., Vachani, A. et al. (2013) The Rac1 splice form Rac1b promotes K-ras-induced lung tumorigenesis. Oncogene, 32, 903-909.
82. Hall, M.P., Nagel, R.J., Fagg, W.S., Shiue, L., Cline, M.S., Perriman, R.J., Donohue, J.P. and Ares, M. (2013) Quaking and PTB control overlapping splicing regulatory networks during muscle cell differentiation. RNA, 19, 627-638.
83. Barash, Y., Calarco, J.A., Gao, W., Pan, Q., Wang, X., Shai, O., Blencowe, B.J. and Frey, B.J. (2010) Deciphering the splicing code. Nature, 465, 53-59.
84. Han, H., Irimia, M., Ross, P.J., Sung, H.-K., Alipanahi, B., David, L., Golipour, A., Gabut, M., Michael, I.P., Nachman, E.N. et al. (2013) MBNL proteins repress ES-cell-specifc alternative splicing and reprogramming. Nature, 498, 241-245.
85. Chen, Y., Tian, D., Ku, L., Osterhout, D.J. and Feng, Y. (2007) The selective RNA-binding protein quaking I (QKI) is necessary and suffcient for promoting oligodendroglia differentiation. J. Biol. Chem., 282, 23553-23560.
86. Singh, R.K., Xia, Z., Bland, C.S., Kalsotra, A., Scavuzzo, M.A., Curk, T., Ule, J., Li, W. and Cooper, T.A. (2014) Rbfox2-coordinated alternative splicing of Mef2d and Rock2 controls myoblast fusion during myogenesis. Mol. Cell, 55, 592-603.
87. Gehman, L.T., Meera, P., Stoilov, P., Shiue, L., O'Brien, J.E., Meisler, M.H., Ares, M., Otis, T.S. and Black, D.L. (2012) The splicing regulator Rbfox2 is required for both cerebellar development and mature motor function. Genes Dev., 26, 445-460.
88. Li, Z., Takakura, N., Oike, Y., Imanaka, T., Araki, K., Suda, T., Kaname, T., Kondo, T., Abe, K. and Yamamura, K. (2003) Defective smooth muscle development in qkI-defcient mice. Dev. Growth Differ., 45, 449-462.
89. Kalsotra, A., Xiao, X., Ward, A.J., Castle, J.C., Johnson, J.M., Burge, C.B. and Cooper, T.A. (2008) A postnatal switch of CELF and MBNL proteins reprograms alternative splicing in the developing heart. Proc. Natl. Acad. Sci. U.S.A., 105, 20333-20338.
90. Anders, S. and Huber, W. (2010) DESeq: Differential expression analysis for sequence count data. Genome Biol., 11, R106.